https://www.selleckchem.com/
Data to date supports the potential for targeting the cutaneous endocannabinoid system to treat eczematous dermatoses. However, our understanding of patient knowledge and utilization of cannabis/cannabis-derived products as treatments for eczema is limited, highlighting both a gap and opportunity to engage with the eczema community. An online survey assessing the use, knowledge, and attitudes of a broad scope of cannabis product types was advertised by the National Eczema Association (NEA) via social media and NEA network dissemination. Of 76 respondents to
Like
Comment
Share
